Altre lingue AbbVie Inc. BOERSE MUENCHEN

Azioni

Tempo reale BOERSE MUENCHEN Altri mercati azionari 13:43:18 20/06/2024			Variaz. 5gg	Var. 1 gen.
160,2 ^EUR	+0,74%		+3,61%	+13,82%

19/06	Prospettive future dell'intelligenza artificiale
18/06	ABBVIE INC. : ancora rating Neutral per Piper Sandler	ZM

KI: Die Zukunftsaussichten	19/06
AbbVie : approbation de la FDA dans la colite ulcéreuse	19/06
U.S. FDA Approves SKYRIZI® (risankizumab-rzaa) for Ulcerative Colitis, Expanding AbbVie's Portfolio Across Inflammatory Bowel Disease	19/06
AbbVie's Skyrizi Gets FDA Approval to Treat Certain Instances of Ulcerative Colitis	18/06
Perspectivas futuras de la IA	18/06
Future prospects for AI	18/06
Les perspectives futures sur l'IA	17/06
AbbVie Says Investors Should Sit Out Tutanota Mini-Tender Offer	14/06
AbbVie Recommends Shareholders Reject Tutanota's "Mini-Tender" Offer	14/06
AbbVie inks immune disorder drug licensing deal with China's FutureGen	13/06
AbbVie, FutureGen in License Pact for Inflammatory Bowel Disease Drug	13/06
AbbVie, FutureGen to Develop Potential Inflammatory Bowel Disease Treatment	13/06
AbbVie and FutureGen Announce License Agreement to Develop Next-Generation Therapy for Inflammatory Bowel Disease	13/06
3 Top-Picks: Auf medizinische KI setzen	13/06
BOTOX® Cosmetic (onabotulinumtoxinA) Reveals 2024 Women Entrepreneur Grant Recipients	11/06
Drie bedrijven om in te zetten op medische AI	11/06
Alvotech Expands Alliance with STADA to Include Denosumab Biosimilar	11/06
Three companies to bet on medical AI	10/06
Global markets live: ABB, Roche, Microsoft, Apple, Tesla...	10/06
Tres empresas para capitalizar la IA médica	10/06

Non ci sono risultati per questa ricerca